European Patent Office

T 0663/02 of 17.03.2011

European Case Law Identifier
ECLI:EP:BA:2011:T066302.20110317
Date of decision
17 March 2011
Case number
T 0663/02
Petition for review of
-
Application number
96944505.5
IPC class
G01R 33/563
Language of proceedings
English
Distribution
Distributed to board chairmen and members (B)
OJ versions
No OJ links found
Other decisions for this case
-
Abstracts for this decision
-
Application title
Method for magnetic resonance imaging of arteries using a magnetic resonance contrast agent
Applicant name
Prince, Martin, R.
Opponent name
Koninklijke Philips Electronics N.V.
Board
3.4.01
Headnote

I. The fact that an intravenous injection of a magnetic resonance contrast agent can be delegated by a physician to a qualified paramedical professional indicates that such an injection may be considered as representing a minor routine intervention which does not imply a substantial health risk when carried out with the required care and skill. Such acts would be ruled out from the scope of the application of the exclusion clause pursuant to Article 53(c) EPC following the narrow understanding advocated by the EBA (G 0001/04 and 0001/07) (Reasons, 3.2.4).

II. A possible way of assessing health risks is to use a risk matrix permitting to combine the levels of likelihood and health impact of a complication of a medical act with regard to a large number of patients, so as to obtain statistical health risk scores which may be used to decide what action should be taken. Such a risk assessment supports the view that an intravenous injection of a magnetic resonance contrast agent represents a minor routine intervention involving no substantial health risks when carried out with the required care and skill (Reasons, 3.2.5).

Relevant legal provisions
European Patent Convention Art 53(c)
Keywords
-
Catchword
-

ORDER

For these reasons it is decided that:

1. The decision under appeal is set aside.

2. The patent is maintained as granted.